Skip to main content

Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2.

Publication ,  Conference
Gwin, WR; Hobeika, A; Osada, T; Hartman, Z; Cheng, Q; Broadwater, G; Kimmick, GG; Blackwell, KL; Morse, M; Lyerly, K
Published in: Journal of Clinical Oncology
May 20, 2015

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2015

Volume

33

Issue

15_suppl

Start / End Page

3081 / 3081

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gwin, W. R., Hobeika, A., Osada, T., Hartman, Z., Cheng, Q., Broadwater, G., … Lyerly, K. (2015). Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2. In Journal of Clinical Oncology (Vol. 33, pp. 3081–3081). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.3081
Gwin, William Rayford, Amy Hobeika, Takuya Osada, Zachary Hartman, Qing Cheng, Gloria Broadwater, Gretchen Genevieve Kimmick, Kimberly L. Blackwell, Michael Morse, and Kim Lyerly. “Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2.” In Journal of Clinical Oncology, 33:3081–3081. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.3081.
Gwin WR, Hobeika A, Osada T, Hartman Z, Cheng Q, Broadwater G, et al. Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 3081–3081.
Gwin, William Rayford, et al. “Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2.Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 3081–3081. Crossref, doi:10.1200/jco.2015.33.15_suppl.3081.
Gwin WR, Hobeika A, Osada T, Hartman Z, Cheng Q, Broadwater G, Kimmick GG, Blackwell KL, Morse M, Lyerly K. Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 3081–3081.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2015

Volume

33

Issue

15_suppl

Start / End Page

3081 / 3081

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences